Targeted modification of rat genome
Compositions and methods are provided for modifying a rat genomic locus of interest using a large targeting vector (LTVEC) comprising various endogenous or exogenous nucleic acid sequences as described herein. Compositions and methods for generating a genetically modified rat comprising one or more targeted genetic modifications in their germline are also provided. Compositions and methods are provided which comprise a genetically modified rat or rat cell comprising a targeted genetic modification in the rat interleukin-2 receptor gamma locus, the rat ApoE locus, the rat Rag2 locus, the rat Rag1 locus and/or the rat Rag2/Rag1 locus. The various methods and compositions provided herein allows for these modified loci to be transmitted through the germline.
1. A rat or a rat embryonic stem (ES) cell comprising a targeted genetic modification comprising a humanized endogenous interleukin-2 receptor gamma genomic locus.
2. The rat or the rat ES cell of claim 1 , wherein the humanized endogenous interleukin-2 receptor gamma genomic locus encodes a fully human interleukin-2 receptor gamma protein.
3. The rat or the rat ES cell of claim 2 , wherein the humanized endogenous interleukin-2 receptor gamma genomic locus comprises a replacement of the entire endogenous rat interleukin-2 receptor gamma coding region with a human interleukin-2 receptor gamma coding region.
4. The rat or the rat ES cell of claim 1 , wherein the humanized endogenous interleukin-2 receptor gamma genomic locus encodes an interleukin-2 receptor gamma protein comprising a human interleukin-2 receptor gamma ecto-domain and a rat interleukin-2 receptor gamma cytoplasmic domain.
5. The rat or the rat ES cell of claim 4 , wherein the humanized endogenous interleukin-2 receptor gamma genomic locus comprises a replacement of an endogenous rat interleukin-2 receptor gamma ecto-domain coding region with a human interleukin-2 receptor gamma ecto-domain coding region.